Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis

The paper presents a detailed algorithm for the treatment and follow-up of patients with recurrent multiple sclerosis and primary progressive multiple sclerosis in the use of ocrelizumab.

Enregistré dans:
Détails bibliographiques
Auteurs principaux: A. N. Boyko, M. V. Davydovskaya, N. V. Khachanova, M. N. Zakharova, N. N. Spirin, E. V. Popova, V. M. Alifirova, Ya. V. Vlasov, S. A. Sivertseva, F. A. Khabirov, M. V. Shumilina, E. P. Evdoshenko
Format: Artigo
Langue:Russo
Publié: IMA-PRESS LLC 2019-11-01
Collection:Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Sujets:
ocrelizumab
multiple sclerosis
recurrent multiple sclerosis
primary progressive multiple sclerosis
monoclonal antibody
Accès en ligne:https://nnp.ima-press.net/nnp/article/view/1168
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires